XBiotech (XBIT) Net Equity Issued and Repurchased (2014 - 2017)
XBiotech (XBIT) posted quarterly Net Equity Issued and Repurchased of -$31.9 million for Q4 2017, down 3229.12% quarter-over-quarter from $1.0 million in Q2 2017.
XBiotech (XBIT) Net Equity Issued and Repurchased (2014 - 2017) Analysis & Trends
XBiotech's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$31.9 million for Q4 2017.
- In Q4 2017, Net Equity Issued and Repurchased changed N/A year-over-year to -$31.9 million; the TTM figure through Dec 2017 stood at $1.7 million (changed N/A YoY), while the FY2020 annual figure was $10.3 million, up 171.05% from the prior year.
- Net Equity Issued and Repurchased for Q4 2017 stood at -$31.9 million, down from $1.0 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $73.6 million in Q2 2015, with the low at -$31.9 million in Q4 2017.
- The 3-year median for Net Equity Issued and Repurchased is $4.1 million (2014), against an average of $14.1 million.
- Peak annual rise in Net Equity Issued and Repurchased reached 79.31% in 2015, while the deepest fall reached 100.75% in 2015.
- XBiotech's Net Equity Issued and Repurchased stood at $46.0 million in 2014, then sank by 100.75% to -$343000.0 in 2015, then slumped by 9205.25% to -$31.9 million in 2017.
- Business Quant data shows XBIT's Net Equity Issued and Repurchased at -$31.9 million in Q4 2017, $1.0 million in Q2 2017, and $32.6 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -31.92 Mn |
| Dec 31, 2017 | -31.92 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Mar 31, 2017 | 32.62 Mn |
| Mar 31, 2017 | 32.62 Mn |
| Dec 31, 2015 | -343,000.00 |
| Dec 31, 2015 | -343,000.00 |
| Sep 30, 2015 | 30,000.00 |
| Sep 30, 2015 | 30,000.00 |
| Jun 30, 2015 | 73.62 Mn |
| Jun 30, 2015 | 73.62 Mn |
| Mar 31, 2015 | 2.40 Mn |
| Mar 31, 2015 | 2.40 Mn |
| Dec 31, 2014 | 46.02 Mn |
| Dec 31, 2014 | 46.02 Mn |
| Sep 30, 2014 | 5.75 Mn |
| Sep 30, 2014 | 5.75 Mn |
| Mar 31, 2014 | 11.61 Mn |
| Mar 31, 2014 | 11.61 Mn |